APOA1 Antikörper (AA 19-267)
Kurzübersicht für APOA1 Antikörper (AA 19-267) (ABIN7111656)
Target
Alle APOA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 19-267
-
Verwendungszweck
- APOA1 antibody
-
Aufreinigung
- Protein A+G purification
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
-
Immunogen sequence: 19-267aa
Immunogen: apolipoprotein A-I
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- WB: 1:1000-1:4000, IHC: 1:50-1:500, IF: 1:50-1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Andere Bezeichnung
- APOA1
-
Hintergrund
-
Synonyms: Apolipoprotein A-I (Apo-AI, ApoA-I)|Apolipoprotein A1|Proapolipoprotein A-I (ProapoA-I)|Truncated apolipoprotein A-I Alternative names: Apolipoprotein A-I(1-242)|APOA1
Background: Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase(LCAT). As part of the SPAP complex, activates spermatozoa motility.
-
Molekulargewicht
- 26-28 kDa
-
Gen-ID
- 335
-
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-